ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax

BAUDETTE, Minn., May 7, 2018 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has completed the acquisition of a portfolio of six generic products, related manufacturing and su... Biopharmaceuticals, Generics, Acquisitions ANI Pharmaceuticals, Amneal Pharmaceuticals, Impax Laboratories, Simvastatin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news